CLEVELAND, October 4, 2023–(BUSINESS WIRE)–Medical device and technology company Lazurite® today announced that Christopher (Chris) S. Proctor, M.D., of De La Vina Surgicenter in Santa Barbara, California, has joined the company’s medical advisory board.
Proctor specializes in sports medicine, shoulder, knee and arthroscopic surgery. He is the team physician for the University of California, Santa Barbara, baseball team and the Santa Barbara Foresters baseball team of the California Collegiate League. He is also a staff physician for the University of California, Santa Barbara, and provides sports medicine care for numerous high school, collegiate and professional athletes.
“We are honored to have Dr. Proctor join our medical advisory board,” Lazurite CEO and cofounder Eugene Malinskiy said. “He was an early adopter of our ArthroFree® Wireless Surgical Camera System and has provided significant insight into the customer experience of adopting a wireless surgical camera. In addition to his accomplishments as a physician, he has also developed and patented devices, so he understands and appreciates innovation in medicine.”
“I’m excited about joining Lazurite’s medical advisory board,” Proctor said. “We have performed dozens of procedures since we installed our ArthroFree system. I look forward to continuing to provide input to the company as it accelerates the evolution of the OR to wireless surgical cameras.”
Proctor is a magna cum laude graduate of UCLA and received his medical education at Columbia University in New York. He was then selected as the prestigious Frank E. Stinchfield Fellow in Orthopaedic Surgery at Columbia and conducted biomechanics research. He completed his orthopedic residency at Columbia-Presbyterian Medical Center. He then completed an advanced fellowship with the renowned Southern California Center for Sports Medicine.
Proctor has conducted extensive research on the structure, function and repair of joints and has published numerous articles and book chapters. He has presented his findings and is a speaker at scientific meetings in the United States and Europe. He also has developed and patented devices to prevent and rehabilitate athletic injuries and is currently investigating novel techniques for repairing shoulders and knees. He also serves as an editorial reviewer for leading orthopedic journals. He is board certified and is a member of the American Academy of Orthopedic Surgeons, the Arthroscopy Association of North America and the American Shoulder and Elbow Surgeons.
Lazurite’s wireless ArthroFree system is designed to help surgeons stay focused under pressure when it is most critical. With no cords to distract a surgeon’s attention, we expect that they can fully concentrate on the patient’s procedure. ArthroFree has been used in centers of excellence around the country with outstanding results. For more information, contact an ArthroFree product expert at: (833) 214-2324 or firstname.lastname@example.org.
Lazurite designs medtech devices. Its ArthroFree® System is the first wireless camera with FDA clearance for arthroscopy and general endoscopy. The ArthroFree System is designed to enhance the surgeon’s focus during the critical moments of surgery by enabling untethered movement and dexterity. It promises to increase the safety and efficiency of minimally invasive surgical procedures while decreasing the cost. Lazurite’s IP portfolio includes the high-efficiency Meridiem® light technology, wireless communication technology, and products in development. Lazurite’s three-year vision (by 2026): Modernize 1,000 operating rooms for the wireless age. For more information, see https://lazurite.co.
This press release includes “forward-looking statements.” Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “projected,” “estimate,” “expect,” “may,” “should,” “will,” “designed,” “optimistic,” “promises,” “helps,” “allows” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the expected impact and ease of use advantages of the ArthroFree System within the field of minimally invasive surgery, particularly orthopedic surgery. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Lazurite®, ArthroFree®, and Meridiem® are registered trademarks of Lazurite Holdings LLC.
Visit lazurite.co/mediafor videos, logos, images, fact sheets, bios and more.
+1 (216) 233-7473
+1 (216) 334-3127